rising prevalence of pneumonia and concerns associated with pneumonia mortality is driving the Pneumonia Testing Market
Technavio analyzes that the Pneumonia Testing Market is expected to grow at a CAGR of 5.69% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 807.5 million.There are various factors that contribute to the growth of the market. The global pneumonia testing market is experiencing significant growth due to the increasing prevalence of pneumonia and the associated concerns regarding mortality rates. Pneumonia, an inflammatory condition of the lungs, affects people of all ages, but it is particularly dangerous for infants, older adults, and individuals with weakened immune systems. Early and accurate diagnosis is crucial for effective treatment and reducing the risk of complications and fatalities. Advancements in diagnostic technologies, such as imaging techniques and laboratory tests, are driving innovation in the pneumonia testing market. These technologies enable healthcare professionals to diagnose pneumonia more quickly and accurately, improving patient outcomes and reducing healthcare costs. Additionally, increasing public awareness and healthcare infrastructure development in emerging economies are expected to boost market growth.
In the realm of diagnostics, pneumonia testing is a critical medical application that adheres to guidelines from organizations such as the American Thoracic Society (ATS), Infectious Diseases Society of America (IDSA), and the College of American Pathologists (CAP). Vendors like Curetis and GE Healthcare provide advanced solutions for early detection of Streptococcus pneumoniae, a leading cause of pneumonia. Their offerings include the Thoracic Care Suite and Xpert® Pneumonia, respectively. These solutions utilize consumables such as PCR assays, nucleic acid detection kits, staining materials, elimination kits and reagents, standards, and controls. Meridian Bioscience Inc. (Meridian) is a key supplier of pneumonia test kits, including the PlasmoTest, which offers reliable visual detection assays for this medical condition. These assays can be purchased individually or as part of the kit, ensuring flexibility for pharmaceutical companies and biomedical research organizations.
Know which region is leading the market growth by requesting a sample report
Pneumonia Testing Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The Pneumonia Testing Industry is witnessing significant growth due to the increasing prevalence of pneumonia in the geriatric population and children, driven by sedentary lifestyles, unhealthy food habits, and environmental factors. Traditional methods like cultures are time-consuming and have high error rates, leading to the adoption of advanced technologies such as nucleic acid detection, immunofluorescence, and POC testing using analyzers from companies like Curetis and GE Healthcare. Reimbursements and healthcare expenditure are key factors influencing market growth. Antibiotics and antifungals are commonly used treatments, but accurate diagnostics are crucial to ensure effective therapy. Guidelines from organizations like ATS, IDSA, and CAP recommend early and accurate diagnosis to improve patient outcomes. The prevalence of pneumonia caused by Streptococcus pneumoniae and other pathogens continues to fuel market demand. Consumables and analyzers are essential components of these advanced diagnostic solutions.
The global life sciences tools and services market encompasses organizations involved in the research and development (R&D) of various product categories, including diagnostic instruments and consumables for pneumonia testing. Factors driving market growth include the expanding geriatric population, increasing healthcare expenditure, and the need for accurate pneumonia diagnostics. Technavio projects that key market trends will include the adoption of advanced techniques such as nucleic acid detection and the use of antibiotics and antifungals. Reimbursement policies and key market players, including Thermo Fisher Scientific, Abbott, and Roche, will also impact market dynamics. Traditional methods, such as cultures, continue to be used but are being increasingly replaced by more efficient and accurate diagnostic tools.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
